NIH-funded research R01 grant

Using RNA delivery to improve heart function in patients with contractile disorders

Official title: Cardiac delivery of RNA to treat contractile disorder

Funded at University of Pennsylvania · NIH-11117128 · Data updated 2026-11-12

This study is testing a new way to deliver helpful RNA directly to the heart using tiny particles, aiming to improve heart function for people with conditions that make it hard for their heart to pump effectively.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionUniversity of Pennsylvania
NIH-funded
Lab location1 site (Philadelphia, United States)
Project startJuly 1, 2024
Project endApril 30, 2028
Funding year2025
Award (this year)$716,989
NIH project number5R01HL169448-02
Project IDNIH-11117128 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are individuals diagnosed with heart failure or other conditions that impair heart contractility.

Less likely to help

Patients with stable heart function or those not experiencing contractile dysfunction may not benefit from this research.

What this research studies

This research focuses on developing a new method to deliver therapeutic RNA directly to the heart to treat contractile disorders, which affect the heart's ability to pump effectively. The approach utilizes specially designed lipid nanoparticles that can efficiently transport RNA molecules to cardiac cells. By targeting specific proteins involved in heart function, the goal is to improve heart contractility and overall cardiac health. Patients may be involved in studies that assess the effectiveness of these treatments in improving heart function.

Why it matters

Potential benefit: If successful, this research could lead to new therapies that significantly improve heart function in patients with contractile disorders.

How similar studies have gone: Other research has shown promise in using lipid nanoparticles for RNA delivery, particularly in the context of mRNA vaccines, suggesting a potential for success in this novel application.

Where this research is happening

  • University of Pennsylvania
    Philadelphia, United States
    Active

Researchers

  • Principal investigator: Margulies, Kenneth Ber — University of Pennsylvania
  • Study coordinator: Margulies, Kenneth Ber

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.